HROW CIK: 1360214

Harrow Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
60.7
FY22:
118
FY23:
139
FY24:
190
FY25:
212
(positive)
Change from FY21 to FY25
millions USD
FY21:
37.7
FY22:
39.1
FY23:
173
FY24:
199
FY25:
188
Total assets
Change from FY21 to FY25
millions USD
FY21:
98.3
FY22:
157
FY23:
312
FY24:
389
FY25:
399

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
9.72
FY22:
18.6
FY23:
49.3
FY24:
91.3
FY25:
96.3
(negative)
Change from FY21 to FY25
millions USD
FY21:
77.7
FY22:
112
FY23:
192
FY24:
228
FY25:
251
(positive)
Change from FY21 to FY25
millions USD
FY21:
11.3
FY22:
27.6
FY23:
70.8
FY24:
69.7
FY25:
52.4
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
98.7
FY22:
158
FY23:
313
FY24:
389
FY25:
400

All amounts in millions USD Data source:SEC EDGAR